Altamira Therapeutics Ltd. Interest Expense On Lease Liabilities
Altamira Therapeutics Ltd. (CYTOF) reported Interest Expense On Lease Liabilities of $11.46 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseOnLeaseLiabilities · last filed 2025-04-30
USD
| Period end | Interest Expense On Lease Liabilities 12 month |
|---|---|
| 2024-12-31 | $11.46K 20-F · filed 2025-04-30 |
| 2023-12-31 | $21.47K 20-F · filed 2025-04-30 |
| 2021-12-31 | $3.00K 20-F · filed 2022-04-12 |
CHF
| Period end | Interest Expense On Lease Liabilities 12 month |
|---|---|
| 2023-12-31 | 19.29K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 15.95K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 3.00K CHF 20-F · filed 2023-05-16 |